No abstract available
MeSH terms
-
Antineoplastic Protocols
-
Clinical Trials, Phase III as Topic
-
Clone Cells / pathology
-
Drug Resistance, Neoplasm / drug effects
-
Drug Resistance, Neoplasm / genetics
-
Fusion Proteins, bcr-abl / genetics*
-
Fusion Proteins, bcr-abl / metabolism
-
Humans
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / physiopathology
-
Mutation
-
Protein Kinase Inhibitors / administration & dosage*
-
Protein Kinase Inhibitors / therapeutic use
-
Protein-Tyrosine Kinases / genetics*
-
Protein-Tyrosine Kinases / metabolism
-
Treatment Failure
Substances
-
Protein Kinase Inhibitors
-
Protein-Tyrosine Kinases
-
Fusion Proteins, bcr-abl